Symbols / RA Stock $12.74 +1.59% Brookfield Real Assets Income Fund Inc.
RA (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteBrookfield Real Assets Income Fund Inc. is a closed ended fixed income mutual fund launched and managed by Brookfield Investment Management Inc. The fund is co-managed by Schroder Investment Management North America Inc. It invests in fixed income markets of the United States. The fund primarily invests in securities and other instruments of companies, which includes real estate securities, infrastructure securities, and natural resources securities. Brookfield Real Assets Income Fund Inc. was formed on December 2, 2016 and is domiciled in the United States.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2012-07-25 | main | JP Morgan | — → Neutral | $28 |
| 2012-07-24 | down | Raymond James | Strong Buy → Market Perform | — |
| 2012-07-24 | down | Morgan Stanley | Overweight → Underweight | — |
News
RSS: Latest RA news- 9,366 RSUs granted to Acrivon (ACRV) director for RA Capital funds - Stock Titan Wed, 20 May 2026 20
- Supreme Court Remands Ra Deok-yeon Case, Citing CFD Violations - 조선일보 Wed, 20 May 2026 05
- Insider Sale: Director at $RA Sells 2,750 Shares - Quiver Quantitative hu, 14 May 2026 13
- New Immunovant drug posts 72.7% response rate in tough arthritis cases - Stock Titan Wed, 20 May 2026 11
- Top Court Rules CFD Orders Can Constitute Stock Manipulation in Ra Duck-yeon Case - Seoul Economic Daily Wed, 20 May 2026 14
- Karyopharm Announces $30 Million Private Placement with RA Capital - Karyopharm ue, 24 Mar 2026 07
- Trent’s Growth Story Is Intact, But Stock Awaits Breakout Confirmation: SEBI RA Rajneesh Sharma - MSN Sat, 16 May 2026 06
- (RA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily Fri, 15 May 2026 08
- Supreme Court weighs final sentence for Korea stock-rigging ringleader Ra Deok-yeon - CHOSUNBIZ - Chosunbiz ue, 19 May 2026 21
- Cullinan trial drug depletes B cells in refractory arthritis and lupus - Stock Titan Mon, 18 May 2026 21
- RA Capital group reports 2,611,733 Dianthus shares (DNTH) - Stock Titan Fri, 15 May 2026 20
- RA Capital affiliates report 1.296M shares of Contineum (CTNM) - Stock Titan Fri, 15 May 2026 20
- RA Capital affiliates hold 2.80M shares in Unicycive (UNCY) under 9.99% blocker - Stock Titan Fri, 15 May 2026 20
- RA Capital and principals report 9.99% stake in Avalo Therapeutics (AVTX) - Stock Titan Fri, 15 May 2026 20
- RA Capital affiliates report 9.99% of 4D Molecular (NASDAQ: FDMT) via warrants and shares - Stock Titan Fri, 15 May 2026 20
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
64.90
-3.87%
|
67.52
-20.45%
|
84.87
+170.84%
|
-119.82
|
| Operating Revenue |
|
64.90
-3.87%
|
67.52
-20.45%
|
84.87
+170.84%
|
-119.82
|
| Operating Expense |
|
3.02
-3.19%
|
3.12
+1.93%
|
3.06
-9.04%
|
3.37
|
| Selling General And Administration |
|
2.96
-3.30%
|
3.06
+1.78%
|
3.01
-9.35%
|
3.32
|
| General And Administrative Expense |
|
2.96
-3.30%
|
3.06
+1.78%
|
3.01
-9.35%
|
3.32
|
| Other Operating Expenses |
|
0.06
+2.59%
|
0.06
+9.96%
|
0.06
+11.65%
|
0.05
|
| Net Income |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Pretax Income |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Net Interest Income |
|
56.55
-6.13%
|
60.24
+13.72%
|
52.97
+10.06%
|
48.13
|
| Interest Expense |
|
13.12
+8.85%
|
12.05
-8.65%
|
13.19
+40.51%
|
9.39
|
| Interest Income |
|
69.67
-3.63%
|
72.29
+9.26%
|
66.17
+15.03%
|
57.52
|
| Gain On Sale Of Security |
|
2.98
+256.21%
|
-1.91
-654.08%
|
0.34
+169.78%
|
-0.49
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Net Income From Continuing Operation Net Minority Interest |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Net Income From Continuing And Discontinued Operation |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Net Income Continuous Operations |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Normalized Income |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Net Income Common Stockholders |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Diluted EPS |
|
—
|
1.18
-21.33%
|
1.50
+169.77%
|
-2.15
|
| Basic EPS |
|
—
|
1.18
-21.33%
|
1.50
+169.77%
|
-2.15
|
| Basic Average Shares |
|
—
|
54.57
+0.06%
|
54.54
-4.81%
|
57.29
|
| Diluted Average Shares |
|
—
|
54.57
+0.06%
|
54.54
-4.81%
|
57.29
|
| Diluted NI Availto Com Stockholders |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
1,061.11
-2.54%
|
1,088.72
+8.49%
|
1,003.56
-15.43%
|
1,186.60
|
| Cash And Cash Equivalents |
|
1.70
-22.00%
|
2.18
+1116.19%
|
0.18
-94.37%
|
3.19
|
| Cash Financial |
|
1.70
-22.00%
|
2.18
+1116.19%
|
0.18
-94.37%
|
3.19
|
| Receivables |
|
12.35
+3.45%
|
11.94
-5.39%
|
12.62
-25.34%
|
16.90
|
| Prepaid Assets |
|
0.02
+5.99%
|
0.02
+6.41%
|
0.02
-17.90%
|
0.02
|
| Investments And Advances |
|
1,046.68
-2.56%
|
1,074.22
+8.45%
|
990.56
-15.07%
|
1,166.31
|
| Total Liabilities Net Minority Interest |
|
265.97
-4.06%
|
277.21
+57.90%
|
175.57
-44.94%
|
318.87
|
| Payables |
|
5.33
-75.06%
|
21.36
+244.92%
|
6.19
+104.76%
|
3.02
|
| Accounts Payable |
|
4.30
-78.85%
|
20.32
+482.40%
|
3.49
+121.13%
|
1.58
|
| Other Payable |
|
1.03
-1.15%
|
1.04
-61.48%
|
2.70
+86.92%
|
1.45
|
| Long Term Debt And Capital Lease Obligation |
|
260.02
+1.70%
|
255.66
+51.10%
|
169.20
-46.38%
|
315.57
|
| Stockholders Equity |
|
795.14
-2.02%
|
811.50
-1.99%
|
828.00
-4.58%
|
867.73
|
| Common Stock Equity |
|
795.14
-2.02%
|
811.50
-1.99%
|
828.00
-4.58%
|
867.73
|
| Capital Stock |
|
957.72
-3.11%
|
988.44
-2.39%
|
1,012.69
-7.25%
|
1,091.86
|
| Common Stock |
|
957.72
-3.11%
|
988.44
-2.39%
|
1,012.69
-7.25%
|
1,091.86
|
| Share Issued |
|
55.25
+0.00%
|
55.25
-0.37%
|
55.46
-0.45%
|
55.71
|
| Ordinary Shares Number |
|
55.25
+0.00%
|
55.25
-0.37%
|
55.46
-0.45%
|
55.71
|
| Retained Earnings |
|
-162.58
+8.11%
|
-176.94
+4.20%
|
-184.69
+17.60%
|
-224.13
|
| Total Equity Gross Minority Interest |
|
795.14
-2.02%
|
811.50
-1.99%
|
828.00
-4.58%
|
867.73
|
| Total Capitalization |
|
1,055.16
-1.13%
|
1,067.16
+7.02%
|
997.20
-15.73%
|
1,183.30
|
| Invested Capital |
|
1,055.16
-1.13%
|
1,067.16
+7.02%
|
997.20
-15.73%
|
1,183.30
|
| Total Debt |
|
260.02
+1.70%
|
255.66
+51.10%
|
169.20
-46.38%
|
315.57
|
| Net Debt |
|
258.31
+1.91%
|
253.48
+49.97%
|
169.02
-45.89%
|
312.38
|
| Net Tangible Assets |
|
795.14
-2.02%
|
811.50
-1.99%
|
828.00
-4.58%
|
867.73
|
| Tangible Book Value |
|
795.14
-2.02%
|
811.50
-1.99%
|
828.00
-4.58%
|
867.73
|
| Cash Cash Equivalents And Federal Funds Sold |
|
1.70
-22.00%
|
2.18
+1116.19%
|
0.18
-94.37%
|
3.19
|
| Derivative Product Liabilities |
|
0.23
|
—
|
—
|
—
|
| Financial Assets Designatedas Fair Value Through Profitor Loss Total |
|
1,046.68
-2.54%
|
1,073.91
+8.42%
|
990.55
-15.07%
|
1,166.31
|
| Investmentin Financial Assets |
|
1,046.68
-2.56%
|
1,074.22
+8.45%
|
990.56
-15.07%
|
1,166.31
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
73.37
+2154.37%
|
-3.57
-101.36%
|
263.32
+156.04%
|
102.85
|
| Net Income From Continuing Operations |
|
61.88
-3.90%
|
64.39
-21.29%
|
81.81
+166.41%
|
-123.18
|
| Other Non Cash Items |
|
0.45
+103.78%
|
-11.97
-336.46%
|
-2.74
+40.58%
|
-4.62
|
| Gain Loss On Investment Securities |
|
12.73
+117.72%
|
-71.84
-140.28%
|
178.37
-29.71%
|
253.78
|
| Net Foreign Currency Exchange Gain Loss |
|
-0.04
-7809.80%
|
0.00
|
—
|
—
|
| Change In Working Capital |
|
-1.66
-110.47%
|
15.85
+169.35%
|
5.88
+125.44%
|
-23.14
|
| Change In Receivables |
|
-1.85
-371.34%
|
0.68
-84.11%
|
4.28
+164.23%
|
-6.67
|
| Change In Prepaid Assets |
|
-0.00
+0.62%
|
-0.00
-129.40%
|
0.00
+182.96%
|
-0.01
|
| Change In Accrued Expense |
|
0.21
+1075.12%
|
0.02
+116.90%
|
-0.10
-1434.26%
|
0.01
|
| Change In Payable |
|
-0.02
-100.12%
|
15.32
+796.53%
|
1.71
+110.41%
|
-16.43
|
| Change In Other Current Assets |
|
—
|
-0.17
-2086.78%
|
-0.01
+82.25%
|
-0.04
|
| Change In Other Current Liabilities |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Financing Cash Flow |
|
-73.89
-1425.82%
|
5.57
+102.09%
|
-266.33
-149.69%
|
-106.67
|
| Net Issuance Payments Of Debt |
|
5.00
-94.22%
|
86.46
+159.07%
|
-146.37
-63.74%
|
-89.39
|
| Issuance Of Debt |
|
5.00
-94.22%
|
86.46
+5201.20%
|
1.63
|
—
|
| Repayment Of Debt |
|
—
|
—
|
-148.00
|
—
|
| Long Term Debt Issuance |
|
5.00
-94.22%
|
86.46
+5201.20%
|
1.63
|
—
|
| Long Term Debt Payments |
|
—
|
—
|
-148.00
|
—
|
| Net Long Term Debt Issuance |
|
5.00
-94.22%
|
86.46
+159.07%
|
-146.37
-63.74%
|
-89.39
|
| Net Common Stock Issuance |
|
—
|
-2.54
+30.35%
|
-3.65
-103.45%
|
105.64
|
| Common Stock Payments |
|
—
|
-2.54
+59.05%
|
-6.21
|
—
|
| Common Stock Dividend Paid |
|
-78.24
+0.14%
|
-78.35
+32.64%
|
-116.31
+5.37%
|
-122.92
|
| Cash Dividends Paid |
|
-78.24
+0.14%
|
-78.35
+32.64%
|
-116.31
+5.37%
|
-122.92
|
| Repurchase Of Capital Stock |
|
—
|
-2.54
+59.05%
|
-6.21
|
—
|
| Net Other Financing Charges |
|
-0.65
|
0.00
|
0.00
|
0.00
|
| Changes In Cash |
|
-0.52
-125.89%
|
2.00
+166.57%
|
-3.01
+21.30%
|
-3.82
|
| Effect Of Exchange Rate Changes |
|
0.04
+7809.80%
|
-0.00
|
—
|
—
|
| Beginning Cash Position |
|
2.18
+1116.19%
|
0.18
-94.37%
|
3.19
-54.53%
|
7.01
|
| End Cash Position |
|
1.70
-22.00%
|
2.18
+1116.19%
|
0.18
-94.37%
|
3.19
|
| Free Cash Flow |
|
73.37
+2154.37%
|
-3.57
-101.36%
|
263.32
+156.04%
|
102.85
|
| Common Stock Issuance |
|
—
|
—
|
2.56
-97.58%
|
105.64
|
| Issuance Of Capital Stock |
|
—
|
—
|
2.56
-97.58%
|
105.64
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-05-14 View
- 42024-12-16 View
- 42024-09-18 View
- 42023-12-15 View
- 42023-09-13 View
- 42023-09-07 View
- 42023-09-06 View
- 42023-08-31 View
- 42023-01-10 View
- 42022-07-06 View
- 42022-03-08 View
- 42021-03-09 View
- 42020-06-04 View
- 42020-06-02 View
- 42020-03-27 View
- 42020-03-25 View
- 42020-03-25 View
- 42020-03-25 View
- 42020-03-25 View
- 42020-03-25 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|